![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Kyongbo Pharmaceutical Co., Ltd. Asan-si Kr, based in South Korea, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Bacampicillin Hydrochloride, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2002-216 - Rev 01
This Chemical Type CEP, issued on November 18, 2004, remains in force until October 02, 2008, ensuring its reliability within the pharmaceutical industry.
Substance Number 808 associated with this CEP further emphasizes